Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Agenus
Aug 11, 2025
[10-Q] Agenus Inc. Quarterly Earnings Report
Aug 11, 2025
[Form 4] Agenus Inc. Insider Trading Activity
Aug 11, 2025
[8-K] Agenus Inc. Reports Material Event
Jul 28, 2025
[Form 4] Agenus Inc. Insider Trading Activity
Jul 16, 2025
[SCHEDULE 13G/A] Agenus Inc. SEC Filing
144.66M
26.88M
1.94%
33.79%
8.26%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
LEXINGTON